Form4insider filings, from the source

SEC Form 4 · accession 0001213900-18-002972

REGENERX BIOPHARMACEUTICALS INC · RGRX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Essetifin SPA
10% Owner
Paolo Cavazza
10% Owner
Period of report
Mar 13, 2018
Accepted (ET)
Mar 14, 2018 · 4:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000707511

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F5,F6Mar 13, 2018P11,584,795$0.23A25,506,521D
Common StockF2,F6Mar 13, 2018P6,348,878$0.23A31,855,399D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Convertible Promissory Note (right to buy)F4,F5,F6,F3$0.06Mar 13, 2018P—ASep 12, 2013—Common Stock—2,500,000D

Explanation of responses

Remarks

Exhibit List: Exhibit 99.1 - Joint Filers' Signatures